Section Arrow
Quote
TMCI.NASDAQ
- Treace Medical Concepts
Quotes are at least 15-min delayed:2026/03/12 05:33 EDT
Pre Market
Last
 --
-- (--)
Bid
1.36
Ask
1.8
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 1.39
-0.09 (-6.08%)
Day High 
1.46 
Prev. Close
1.48 
1-M High
2.21 
Volume 
768.16K 
Bid
1.36
Ask
1.8
Day Low
1.36 
Open
1.46 
1-M Low
1.31 
Market Cap 
94.30M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.67 
20-SMA 1.8 
50-SMA 2.23 
52-W High 8.87 
52-W Low 1.31 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.93/-0.81
Enterprise Value
163.87M
Balance Sheet
Book Value Per Share
1.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
212.69M
Operating Revenue Per Share
2.62
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.63-0.33-0.47%36.06PE
Pre Market 69.49 -0.14 -0.20%
ABTAbbott Laboratories110.25-0.3-0.27%29.72PE
Pre Market 110 -0.25 -0.23%
MDTMedtronic plc88.97-0.92-1.02%25.14PE
Pre Market 88.88 -0.09 -0.10%
PACBPacific Biosciences of California1.35-0.015-1.10%-- 
Pre Market 1.36 +0.01 +0.74%
EWEdwards Lifesciences Corp85.09-0.69-0.80%47.39PE
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correctionprocedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.